Novavax (NVAX) - P/S ratio

P/S ratio as of January 2026 (TTM): 1.18

According to Novavax's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -7.74. At the end of 2025 the company had a P/S ratio of 1.36.

P/S ratio history for Novavax from 2001 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	1.36	-30.27%
2024	1.94	136.46%
2023	0.8222	31.11%
2022	0.6271	-93.35%
2021	9.44	-36.78%
2020	14.9	116.33%
2019	6.90	-66.56%
2018	20.6	38.17%
2017	14.9	-32.93%
2016	22.3	-64.37%
2015	62.5	35.26%
2014	46.2	-9.57%
2013	51.1	303.3%
2012	12.7	28.42%
2011	9.86	-98.75%
2010	787	-4.14%
2009	821	567.88%
2008	123	-22.27%
2007	158	192.21%
2006	54.1	89.67%
2005	28.5	97.4%
2004	14.4	-18.25%
2003	17.7	286.66%
2002	4.57	-66.51%
2001	13.6

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Agenus AGEN	1.13	-4.64%	🇺🇸 USA
Sarepta Therapeutics SRPT	0.9451	-20.14%	🇺🇸 USA
Emergent BioSolutions EBS	0.9310	-21.33%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	2.65	123.70%	🇺🇸 USA
AstraZeneca AZN	5.03	325.40%	🇬🇧 UK
Pfizer PFE	2.30	94.63%	🇺🇸 USA
Novartis NVS	4.80	305.61%	🇨🇭 Switzerland
NanoViricides NNVC	N/A	N/A	🇺🇸 USA
GlaxoSmithKline GSK	2.43	105.00%	🇬🇧 UK
Celldex Therapeutics CLDX	668	56,308.13%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Novavax (NVAX)

P/S ratio as of January 2026 (TTM): 1.18